Medical Weight Loss for Grand Island, Nebraska Residents
Grand Island, Nebraska residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Grand Island through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Grand Island Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Grand Island, Nebraska residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Grand Island residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Grand Island address.
Grand Island is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout the greater Grand Island area and central Nebraska, with bilingual Spanish care. Every prescription for Grand Island is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Our telehealth model serves Grand Island and communities across Nebraska with the same flat pricing and the same supervising physician. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Grand Island
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Grand Island
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Grand Island address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Grand Island
Does New Hope Weight Loss treat patients in Grand Island?
Yes. Although the clinic is in Costa Mesa, California, we treat Grand Island, Nebraska residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Grand Island?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Grand Island address in cold-pack packaging.
What do Grand Island patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Grand Island do you serve?
We serve patients from across Grand Island by telehealth, including the greater Grand Island area and central Nebraska, with bilingual Spanish care.
Are there hidden fees for Grand Island patients?
No. Grand Island patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Grand Island, Nebraska by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.